Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Clasificación en acciones #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Precio por acción
$4.84
Capitalización bursátil
$633.18M
Cambio (1 día)
3.20%
Cambio (1 año)
0.00%
País
GB
Comercio Exscientia plc (EXAI)

Categoría

Healthcare
Ratio P/B de Exscientia plc (EXAI)
Ratio P/B al April 2026 TTM: 1.26
Según los informes financieros más recientes y el precio de las acciones de Exscientia plc, el ratio P/B actual (TTM) es 1.26. Al final de 2022, el ratio P/B era 1.36.
Historial del ratio P/B de Exscientia plc desde 2019 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 1.26 -27.40%
2023 1.74 28.33%
2022 1.36 -67.63%
2021 4.20 -85.97%
2020 29.94 -64.81%
2019 85.08 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.2875 318.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.074 380.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.5436 101.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5196 257.76%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5468 101.60%
AU